Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2006-07-05
2010-10-12
Mondesi, Robert B (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S185100, C424S192100, C424S197110, C435S069100, C435S069500, C435S069700, C530S350000, C536S023100, C536S023400, C536S023700
Reexamination Certificate
active
07811591
ABSTRACT:
The invention described herein relates to a chimeric protein comprising the NTHi twitching pilus major subunit protein (PilA) presenting a portion of the NTHi OMP P5 protein. The invention provides for vaccine compositions comprising the recombinant chimeric protein and methods of eliciting an immune response using the recombinant chimeric proteins of the invention.
REFERENCES:
patent: 5766608 (1998-06-01), Kolattukudy et al.
patent: 5843464 (1998-12-01), Bakaletz et al.
patent: 6268171 (2001-07-01), Meyer et al.
patent: 6506581 (2003-01-01), Fleischmann et al.
patent: WO-99/64067 (1999-12-01), None
patent: WO-2005/063802 (2005-07-01), None
Anderson et al., Human serum activities againstHemophilus influenzae, Type B.J. Clin. Invest. 51:31-8 (1972).
Bakaletz et al., Demonstration of type IV pilus expression and a twitching phenotype byHaemophilus influenzae. Infect. Immun. 73(3): 1635-43 (2005).
Bakaletz et al., Evidence for transduction of specific antibodies into the middle ear of parenterally immunized chinchillas after an upper respiratory infection with adenovirus.Clin. Diag. Lab. Immunol. 4(2): 223-5 (1997).
Bakaletz et al., Frequency of fimbriation of nontypableHaemophilus influenzaeand its ability to adhere to chinchilla and human respiratory epithelium.Infect. Immun. 56(2): 331-5 (1988).
Bakaletz et al., Modeling adenovirus type 1-induced otitis media in the chinchilla: Effect on ciliary activity and fluid transport function of eustachian tube mucosal epithelium.J. Infect. Dis. 168: 865-72 (1993).
Bakaletz et al., Protection against development of otitis media induced by nontypeableHaemophilus influenzaeby both active and passive immunization in a chinchilla model of virus-bacterium superinfection.Infect. Immun. 67(6): 2746-62 (1999).
Bakaletz et al., Relative immunogenicity and efficacy of two synthetic chimeric peptides of fimbrin as vaccinogens against nasopharyngeal colonization by nontypeableHaemophilus infulenzaein the chinchilla.Vaccine, 15(9): 955-61 (1997).
Baldwin et al., Effects of otitis media on child development.Am. J. Otol. 14: 601-4 (1993).
Bardy et al., Prokaryotic motility structures.Microbiol. 149: 295-304 (2003).
Barenkamp et al., Outer membrane protein and biotype analysis of pathogenic nontypableHaemophilus influenzae. Infect. Immun. 36(2): 535-40 (1982).
Berman et al., Theoretical cost effectiveness of management options for children with persisting middling ear effusions.Pediatrics. 93: 353-63 (1994).
Black et al., Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children.Ped. Infect. Dis. J. 19(3): 187-95 (2000).
Bright et al., The prevalence of tympanostomy tubes in children in the United States.Am. J. Public Health. 83: 1026-8 (1993).
Catlin et al., The type B capsulation locus ofHaemophilus influenzae: Map location and size.J. Microbiol. 70: 411-22 (1972).
Cimons et al., Lurid reports obscure reality of strep a outbreaks.ASM News. 60: 527-30 (1994).
Clemans et al., Comparative analysis ofHaemophilus influenzaehifA (philin) genes.Infect. Immun. 66(2): 656-63 (1998).
Coleman et al., Chemically defined media for growth ofHaemophilus influenzaestrains.J. Clin. Micro. 41: 4408-10 (2003).
Coleman et al., Molecular cloning, expression, and sequence of the Pilin gene from nontypeableHaemophilus influenzaeM37.Infect. Immunity. 59: 1716-22 (1991).
Daines et al.,Haemophilus influenzaeRd KW20 has virulence properties.J. Med. Microbiol. 52: 277-82 (2003).
Darzin et al., Molecular genetic analysis of type-4 pilus biogenesis and twitching motility usingPseudomonas aeruginosaas a model system—a review.Gene. 192: 109-15 (1997).
DeMaria, et al., Immunization with Outer Membrane Protein P6 from NontypeableHaemophilus influenzaeInduces Bactericidal Antibody and Affords Protection in the Chinchilla Model of Otitis Media.Infection and Immunity, 64(12): 5187-5192 (Dec. 1996).
Devereux et al., A comprehensive set of sequence analysis programs for the VAX.Nucl Acids. Res. 12(1): 387-395 (1984).
Dougherty et al., Identification ofHaemophilus influenzaeRd transformation genes using cassette mutagenesis.Microbiology. 145: 401-9 (1999).
Dougherty et al., The type 4 fimbrial subunit gene ofPasteurella multocida. Vet. Microbiol. 72: 79-90 (2000).
Ehrlich et al., Mucosal biofilm formation of middle-ear mucosa in the chinchilla model of otitis media.JAMA. 287: 1710-5 (2002).
Eskola et al., Efficacy of a pneumococcal conjugate vaccine against acute otitis media.N. Engl. J. Med. 344(6): 403-9 (2001).
Eskola et al., Potential of bacterial vaccines in the prevention of acute otitis media.Ped. Infect. Dis. J. 19(5): S72-8 (2000).
Fleischmann et al., Whole-genome random sequence and assembly ofHaemophilus influenzae Rd. Science,269: 496-512 (1995).
Friedrich et al., Molecular analyses of the natural transformation machinery and identification of pilus structures in the extremely thermophilic bacteriumThermus termophilusstrain HB27.Appl. Environ. Microbiol. 68: 745-55 (2002).
Friedrich et al., Pilin-like proteins in the extremely thermophilic bacteriumThermus thermophilusHB27: Implications in competence for natural transformation and links to type IV pilus biogenesis.Appl. Environ. Microbiol. 69: 3695-700 (2003).
Fussenegger et al., Tranformation competence and type-4 pilus biogenesis inNeisseria gonorrhoeae—a review.Gene. 192: 125-34 (1997).
Genbank Accession No. P45285, Peptide transport periplasmic protein sapA precursor, Sep. 13, 2005.
Genbank Accession No. U32837,Haemophilus InfluenzaeRd KW20 section 152 of 163 of the complete genome, Jun. 2, 2004.
Giebink, Immunology: Promise of New Vaccines, Ped.Infect Dis. J., 13(11): 1064-1068 (1994).
Gilsdorf et al., Role of pili inHaemophilus influenzaeadherence to, and internalization by, respiratory cells.Pediatr. Res. 39: 343-8 (1996).
Gilsdorf et al., Role of pili inHaemophilus influenzaeadherence and colonization.Infect. Immun. 65: 2997-3002 (1997).
Holmes, et al., Adherence of Non-TypeableHaemophilus influenzaePromotes Reorganization of the Actin Cytoskeleton in Human or Chinchilla Epithelial Cellsin vitro, Microbial Pathogenesis, 23: 157-166 (1997).
Hunter et al., Identification of hearing loss in children with otitis media.Ann. Otol. Rhinol. Laryngol. Suppl. 163: 59-61 (1994).
Jansen et al., Immunotoxins: Hybrid molecules combining high specificity and potent cytotoxicity.Immun. Rev. 62: 185-216 (1982).
Jesaitis et al., Compromised host defence onPseudomonas aeruginosabiofilms: Characterization of neutrophil and biofilm interactions.J. Immunol. 171: 4329-39 (2003).
Kaplan et al., Overall cost in the treatment of otitis media.Pediatr. Infect. Dis. J. 16: S9-11 (1997).
Karma et al., Immunological Aspects of Otitis Media: Present Views on Possibilities of Immunoprophylazis of Acute Otitis Media in Infants and Children,Int. J. Pediat. Otorhinolaryngology, 32 (Suppl.): S127-S134 (1995).
Karudapuram et al.,TheHaemophilus influenzae dprABCgenes constitute a competence-inducible operon that requires the product of thetfoX(sxy) gene for transcriptional activation.J. Bacteriology. 179(15): 4815-20 (1997).
Keizer et al., Structure of a pilin monomer fromPseudomonas aeruginosa. J. Biol. Chem. 276: 24186-93 (2001).
Kennedy et al., Passive transfer of antiserum specific for immunogens derived from a nontypeableHaemophilus influenzaeadhesin and lipoprotein D prevents otitis media after heterologous challenge.Infect. Immun. 68(5): 2756-65 2000).
Klausen et al., Biofilm formation byPseudomonas aeruginosawild type, flagella and type IV pili mutants.Mol. Microbiol. 48: 1511-24 (2003).
Klausen et al., Involvement of bacterial migration in the development of complex multicellular structures inPseudomonas aeruginosabiofilms.Mol. Microbiol. 50: 61-8 (2003).
Klein, Role of nontypeableHaemophilus influenzaein pediatric respiratory tract infections.Pedriatr. Infect. Dis. J. 16: S5-8 (1997).
Klein, The burden of otitis media.Vaccine, 19(Suppl. 1): S2-8 (2001).
Kyd et al., Potential of a novel protein, OMP26, from nontypeableHaemophilus influenzaeto enhance pulmonary clearance in a rat model.Infect. Immun.
Bakaletz Lauren O.
Munson, Jr. Robert S.
Baskar Padma V
Marshall & Gerstein & Borun LLP
Mondesi Robert B
Nationwide Children's Hospital, Inc.
LandOfFree
Chimeric vaccine for haemophilus influenzae -induced disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Chimeric vaccine for haemophilus influenzae -induced disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chimeric vaccine for haemophilus influenzae -induced disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4151742